Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma.

CONCLUSION: Cancer stem cell marker CD44 may be a promising target for cancer treatment only in ccRCC.
PMID: 29243496 [PubMed - as supplied by publisher]

Source: Future Medicine: Biomarkers in Medicine - December 17, 2017 Category: Internal Medicine Tags: Biomark Med Source Type: research